Bright Minds Biosciences (NASDAQ:DRUG) entered into an equity distribution agreement providing for an at-the-market equity offering program with Piper Sandler & Co. and Cantor Fitzgerald & Co. The ATM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback